AWAT1
gene geneOn this page
Summary
AWAT1 (acyl-CoA wax alcohol acyltransferase 1, HGNC:23252) is a protein-coding gene on chromosome Xq13.1, encoding Acyl-CoA wax alcohol acyltransferase 1 (Q58HT5). Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters.
The protein encoded by this gene belongs to the diacylglycerol acyltransferase family. It esterifies long chain (wax) alcohols with acyl-CoA-derived fatty acids to produce wax esters. Wax esters are enriched in sebum, suggesting that this enzyme plays a central role in lipid metabolism in skin. Consistent with this observation, this protein is predominantly expressed in the sebaceous gland of the skin.
Source: NCBI Gene 158833 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 58 total
- Druggable target: yes
- MANE Select transcript:
NM_001013579
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23252 |
| Approved symbol | AWAT1 |
| Name | acyl-CoA wax alcohol acyltransferase 1 |
| Location | Xq13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204195 |
| Ensembl biotype | protein_coding |
| OMIM | 300924 |
| Entrez | 158833 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000374521, ENST00000480702
RefSeq mRNA: 1 — MANE Select: NM_001013579
NM_001013579
CCDS: CCDS35321
Canonical transcript exons
ENST00000374521 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001463717 | 70240136 | 70240659 |
| ENSE00001463718 | 70239735 | 70239934 |
| ENSE00001463720 | 70238212 | 70238383 |
| ENSE00001463722 | 70237044 | 70237248 |
| ENSE00003519533 | 70234655 | 70234771 |
| ENSE00003527351 | 70235716 | 70235823 |
| ENSE00003590322 | 70236069 | 70236139 |
Expression profiles
Bgee: expression breadth broad, 43 present calls, max score 93.12.
Top tissues by expression
192 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper leg skin | UBERON:0004262 | 93.12 | gold quality |
| mammalian vulva | UBERON:0000997 | 78.36 | gold quality |
| myocardium | UBERON:0002349 | 62.14 | gold quality |
| endothelial cell | CL:0000115 | 61.91 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 54.16 | gold quality |
| biceps brachii | UBERON:0001507 | 53.75 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 51.78 | gold quality |
| buccal mucosa cell | CL:0002336 | 51.04 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.82 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.63 | gold quality |
| colonic mucosa | UBERON:0000317 | 47.81 | gold quality |
| zone of skin | UBERON:0000014 | 47.49 | gold quality |
| skin of abdomen | UBERON:0001416 | 46.89 | gold quality |
| nipple | UBERON:0002030 | 46.65 | silver quality |
| sural nerve | UBERON:0015488 | 46.60 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 45.43 | gold quality |
| right uterine tube | UBERON:0001302 | 45.27 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 44.99 | gold quality |
| calcaneal tendon | UBERON:0003701 | 44.16 | silver quality |
| deltoid | UBERON:0001476 | 43.66 | gold quality |
| adult organism | UBERON:0007023 | 43.60 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.30 | gold quality |
| skin of leg | UBERON:0001511 | 42.96 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 42.81 | gold quality |
| bone marrow cell | CL:0002092 | 42.58 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| gingiva | UBERON:0001828 | 42.37 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 42.06 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 41.64 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.95 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting AWAT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-3688-5P | 99.12 | 69.67 | 1091 |
| HSA-MIR-625-5P | 99.02 | 68.64 | 2031 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-423-5P | 98.69 | 67.48 | 1522 |
| HSA-MIR-3184-5P | 98.56 | 67.13 | 1491 |
| HSA-MIR-4290 | 98.51 | 65.17 | 907 |
| HSA-MIR-4421 | 97.99 | 64.89 | 701 |
| HSA-MIR-5699-3P | 97.81 | 65.00 | 861 |
| HSA-MIR-4660 | 97.79 | 67.44 | 1328 |
| HSA-MIR-214-5P | 97.34 | 66.50 | 617 |
| HSA-MIR-3657 | 96.33 | 66.29 | 608 |
| HSA-MIR-5002-3P | 95.75 | 67.04 | 542 |
Literature-anchored findings (GeneRIF, showing 1)
- analysis of AWAT1 and AWAT2 substrate specificity and differentiation-specific expression pattern (PMID:15671038)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Awat1 | ENSMUSG00000015665 |
| rattus_norvegicus | Awat1 | ENSRNOG00000026231 |
| drosophila_melanogaster | CG1941 | FBGN0033214 |
| drosophila_melanogaster | Dgat2 | FBGN0033215 |
| drosophila_melanogaster | CG1946 | FBGN0033216 |
| caenorhabditis_elegans | WBGENE00010296 | |
| caenorhabditis_elegans | WBGENE00019464 | |
| caenorhabditis_elegans | WBGENE00020910 | |
| caenorhabditis_elegans | WBGENE00021818 |
Paralogs (6): DGAT2 (ENSG00000062282), MOGAT3 (ENSG00000106384), MOGAT1 (ENSG00000124003), AWAT2 (ENSG00000147160), MOGAT2 (ENSG00000166391), DGAT2L6 (ENSG00000184210)
Protein
Protein identifiers
Acyl-CoA wax alcohol acyltransferase 1 — Q58HT5 (reviewed: Q58HT5)
Alternative names: Diacylglycerol O-acyltransferase 2-like protein 3, Diacylglycerol acyltransferase 2, Long-chain-alcohol O-fatty-acyltransferase 1
All UniProt accessions (1): Q58HT5
UniProt curated annotations — full annotation on UniProt →
Function. Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters. Shows a strong preference for decyl alcohol (C10), with less activity towards C16 and C18 alcohols. Shows a strong preference for saturated acyl-CoAs.
Subcellular location. Endoplasmic reticulum membrane.
Tissue specificity. Predominantly expressed in skin, where it is limited to the sebaceous gland. Expressed in more mature, centrally located cells just before their rupture and sebum release. Also expressed in all tissues except spleen. Expressed at higher level in thymus, prostate and testis.
Similarity. Belongs to the diacylglycerol acyltransferase family.
RefSeq proteins (1): NP_001013597* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007130 | DAGAT | Family |
Pfam: PF03982
Enzyme classification (BRENDA):
- EC 2.3.1.75 — long-chain-alcohol O-fatty-acyltransferase (BRENDA: 24 organisms, 473 substrates, 10 inhibitors, 48 Km, 37 kcat entries)
Substrate kinetics (BRENDA)
17 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| PALMITOYL-COA | 0.0031–0.029 | 6 |
| ARACHIDONOYL-COA | 0.2263–0.2972 | 4 |
| DECANOYL-COA | 0.001–0.0176 | 4 |
| EICOSAPENTAENOYL-COA | 0.1016–0.1312 | 4 |
| LAUROYL-COA | 0.0001–0.0259 | 4 |
| MYRISTOYL-COA | 0.0039–0.0185 | 4 |
| OCTADECATRIENOYL-COA | 0.2809–0.2847 | 4 |
| OCTANOYL-COA | 0.0123–0.0299 | 4 |
| STEAROYL-COA | 0.0192–0.0759 | 4 |
| 11-CIS-RETINOL | 0.0262 | 1 |
| 13-CIS-RETINOL | 0.0352 | 1 |
| 9-CIS-RETINOL | 0.0238 | 1 |
| ALL-TRANS-RETINOL | 0.0236 | 1 |
| HEXADECANOL | 0.044 | 1 |
| HEXAN-1-OL | 2.4 | 1 |
Catalyzed reactions (Rhea), 11 shown:
- hexadecan-1-ol + hexadecanoyl-CoA = hexadecyl hexadecanoate + CoA (RHEA:38167)
- 1,2-di-(9Z-octadecenoyl)-sn-glycerol + (9Z)-octadecenoyl-CoA = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + CoA (RHEA:38219)
- decan-1-ol + (9Z)-octadecenoyl-CoA = decyl (9Z)-octadecenoate + CoA (RHEA:38223)
- hexadecan-1-ol + (9Z)-octadecenoyl-CoA = hexadecyl (9Z)-octadecenoate + CoA (RHEA:38227)
- (9Z)-hexadecen-1-ol + (9Z)-octadecenoyl-CoA = 1-O-(9Z)-hexadecenyl (9Z)-octadecenoate + CoA (RHEA:38231)
- octadecan-1-ol + (9Z)-octadecenoyl-CoA = octadecyl (9Z)-octadecenoate + CoA (RHEA:38235)
- (9Z)-octadecen-1-ol + (9Z)-octadecenoyl-CoA = 1-O-(9Z)-octadecenyl (9Z)-octadecenoate + CoA (RHEA:38239)
- eicosan-1-ol + (9Z)-octadecenoyl-CoA = 1-O-eicosanyl (9Z)-octadecenoate + CoA (RHEA:38243)
- hexadecan-1-ol + (9Z)-hexadecenoyl-CoA = hexadecyl (9Z)-hexadecenoate + CoA (RHEA:38247)
- hexadecan-1-ol + octadecanoyl-CoA = hexadecyl octadecanoate + CoA (RHEA:38251)
- a long chain fatty alcohol + a fatty acyl-CoA = a long-chain alcohol wax ester + CoA (RHEA:38443)
UniProt features (3 total): transmembrane region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q58HT5-F1 | 93.13 | 0.83 |
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-2142753 | Arachidonate metabolism |
| R-HSA-9640463 | Wax biosynthesis |
| R-HSA-1430728 | Metabolism |
| R-HSA-556833 | Metabolism of lipids |
| R-HSA-8848584 | Wax and plasmalogen biosynthesis |
| R-HSA-8978868 | Fatty acid metabolism |
MSigDB gene sets: 33 (showing top):
GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_ARACHIDONATE_METABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS, DURCHDEWALD_SKIN_CARCINOGENESIS_UP, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOBP_FATTY_ACID_METABOLIC_PROCESS, GOCC_ORGANELLE_SUBCOMPARTMENT, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_O_ACYLTRANSFERASE_ACTIVITY
GO Biological Process (3): lipid metabolic process (GO:0006629), wax biosynthetic process (GO:0010025), arachidonate metabolic process (GO:0019369)
GO Molecular Function (4): long-chain-alcohol O-fatty-acyltransferase activity (GO:0047196), obsolete O-acyltransferase activity (GO:0008374), transferase activity (GO:0016740), acyltransferase activity (GO:0016746)
GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Metabolism of lipids | 2 |
| Fatty acid metabolism | 1 |
| Wax and plasmalogen biosynthesis | 1 |
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| primary metabolic process | 1 |
| wax metabolic process | 1 |
| fatty acid derivative biosynthetic process | 1 |
| long-chain fatty acid metabolic process | 1 |
| icosanoid metabolic process | 1 |
| unsaturated fatty acid metabolic process | 1 |
| olefinic compound metabolic process | 1 |
| acyltransferase activity, transferring groups other than amino-acyl groups | 1 |
| catalytic activity | 1 |
| transferase activity | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
762 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AWAT1 | ELOVL2 | Q9NXB9 | 866 |
| AWAT1 | SLC27A1 | Q6PCB7 | 843 |
| AWAT1 | ELOVL3 | Q9HB03 | 755 |
| AWAT1 | FABP4 | P15090 | 741 |
| AWAT1 | DGAT1 | O75907 | 733 |
| AWAT1 | ELOVL1 | Q9BW60 | 718 |
| AWAT1 | ACSL5 | Q9ULC5 | 638 |
| AWAT1 | SREBF1 | P36956 | 601 |
| AWAT1 | SCD | O00767 | 576 |
| AWAT1 | PNPLA2 | Q96AD5 | 575 |
| AWAT1 | MTTP | P55157 | 542 |
| AWAT1 | APOB | P04114 | 520 |
| AWAT1 | ACACA | Q13085 | 520 |
| AWAT1 | PPARA | Q07869 | 488 |
| AWAT1 | FAR2 | Q96K12 | 471 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2ADU8, A2ADU9, A6QP72, F6ZFR0, O74850, O94361, P51658, Q08650, Q16635, Q22267, Q32LS6, Q3UN02, Q41745, Q4V8A1, Q4V9F0, Q502J0, Q54GC1, Q58HT5, Q58NB6, Q5F3X0, Q62730, Q6CF02, Q6E1M8, Q6E213, Q6IV76, Q6IV77, Q6IV78, Q6IV82, Q6IV83, Q6IV84, Q6IWY1, Q6P342, Q6PAZ3, Q6ZPD8, Q7TQA3, Q8LG50, Q8N3Y7, Q8TC12, Q8VD48, Q91WF0
Diamond homologs: A2ADU8, A2ADU9, A6QP72, K7K424, O74850, Q08650, Q28C88, Q2KHS5, Q3KPP4, Q3SYC2, Q4V9F0, Q54GC1, Q58HT5, Q5FVP8, Q5M7F4, Q5M8H5, Q6E1M8, Q6E213, Q6P342, Q6PAZ3, Q6ZPD8, Q70VZ7, Q70VZ8, Q75BY0, Q80W94, Q86VF5, Q91ZV4, Q96PD6, Q96PD7, Q96UY1, Q96UY2, Q9ASU1, Q9DCV3, A1A442, Q9ZVN2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
654 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:70236064:CTCA:C | acceptor_loss | 1.0000 |
| X:70236065:TCA:T | acceptor_loss | 1.0000 |
| X:70236066:CA:C | acceptor_loss | 1.0000 |
| X:70236068:GGT:G | acceptor_gain | 1.0000 |
| X:70236140:GTA:G | donor_loss | 1.0000 |
| X:70236141:TAAG:T | donor_loss | 1.0000 |
| X:70238206:CTTTA:C | acceptor_loss | 1.0000 |
| X:70238207:TTTA:T | acceptor_loss | 1.0000 |
| X:70238208:TTA:T | acceptor_loss | 1.0000 |
| X:70238209:TA:T | acceptor_loss | 1.0000 |
| X:70238211:GGT:G | acceptor_gain | 1.0000 |
| X:70240120:C:CA | acceptor_gain | 1.0000 |
| X:70240130:T:A | acceptor_gain | 1.0000 |
| X:70240133:CAGT:C | acceptor_loss | 1.0000 |
| X:70240134:A:AG | acceptor_gain | 1.0000 |
| X:70240134:AGTT:A | acceptor_gain | 1.0000 |
| X:70240134:AGTTG:A | acceptor_gain | 1.0000 |
| X:70240135:G:GA | acceptor_gain | 1.0000 |
| X:70240135:GT:G | acceptor_gain | 1.0000 |
| X:70240135:GTT:G | acceptor_gain | 1.0000 |
| X:70240135:GTTG:G | acceptor_gain | 1.0000 |
| X:70240135:GTTGG:G | acceptor_gain | 1.0000 |
| X:70234767:CATCT:C | donor_gain | 0.9900 |
| X:70234769:TCT:T | donor_gain | 0.9900 |
| X:70234772:G:GG | donor_gain | 0.9900 |
| X:70236061:T:TA | acceptor_gain | 0.9900 |
| X:70236064:CTCAG:C | acceptor_gain | 0.9900 |
| X:70236065:TCAG:T | acceptor_gain | 0.9900 |
| X:70236066:CAGGT:C | acceptor_gain | 0.9900 |
| X:70236067:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
2162 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:70238358:T:C | F203L | 0.984 |
| X:70238360:C:A | F203L | 0.984 |
| X:70238360:C:G | F203L | 0.984 |
| X:70239746:T:A | V215D | 0.981 |
| X:70240231:T:C | F310L | 0.979 |
| X:70240233:C:A | F310L | 0.979 |
| X:70240233:C:G | F310L | 0.979 |
| X:70239760:T:C | F220L | 0.977 |
| X:70239762:T:A | F220L | 0.977 |
| X:70239762:T:G | F220L | 0.977 |
| X:70238359:T:C | F203S | 0.969 |
| X:70238371:C:A | A207D | 0.969 |
| X:70237155:T:C | F123L | 0.967 |
| X:70237157:C:A | F123L | 0.967 |
| X:70237157:C:G | F123L | 0.967 |
| X:70237167:T:C | F127L | 0.967 |
| X:70237169:C:A | F127L | 0.967 |
| X:70237169:C:G | F127L | 0.967 |
| X:70237228:G:T | R147M | 0.965 |
| X:70236128:T:C | F82L | 0.963 |
| X:70236130:C:A | F82L | 0.963 |
| X:70236130:C:G | F82L | 0.963 |
| X:70237133:C:A | N115K | 0.963 |
| X:70237133:C:G | N115K | 0.963 |
| X:70237095:C:G | H103D | 0.958 |
| X:70237229:G:C | R147S | 0.958 |
| X:70237229:G:T | R147S | 0.958 |
| X:70238362:T:A | V204E | 0.957 |
| X:70239743:T:A | L214Q | 0.954 |
| X:70239755:T:C | F218S | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000328209 (X:70236983 C>G), RS1000680637 (X:70237326 C>A), RS1000746534 (X:70239529 G>T), RS1000908598 (X:70237857 G>A,C,T), RS1001199372 (X:70236694 A>G), RS1002375937 (X:70237855 A>C), RS1002469992 (X:70234544 TG>T,TGG), RS1002667489 (X:70232766 TAAGGA>T), RS1002762080 (X:70235017 A>T), RS1002975897 (X:70239419 T>C), RS1003250808 (X:70239198 C>T), RS1005209484 (X:70238024 G>C), RS1006822624 (X:70239122 C>G), RS1007316386 (X:70240626 A>G), RS1007691882 (X:70240520 C>T)
Disease associations
OMIM: gene MIM:300924 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2375205 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| clothianidin | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2378918 | Binding | Inhibition of human recombinant AWAT1 expressed in insect cell membrane using palmitoleyl alcohol and [14C]stearoyl coenzyme A as substrate after 10 to 15 mins by liquid scintillation counting | Identification and design of a novel series of MGAT2 inhibitors. — Bioorg Med Chem Lett |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.